Journal of heterocyclic chemistry

The synthesis of 4??benzylamino??6??methyl??1H??pyrrolo [3, 2??c] pyridine and 4??benzylamino??6??methyl??1H??pyrrolo [2, 3??b] pyridine

EA Meade, LM Beauchamp

Index: Journal of Heterocyclic Chemistry, , vol. 33, # 2 p. 303 - 308

Full Text: HTML

Citation Number: 10

Abstract

... The Synthesis of 4-Benzylamino-6-methyl-l#-pyrrolo[3,2-c]pyridine and4-Benzylamino-6-methyl- l#-pyrrolo[2,3-fr]pyridine Eric A. Meade* and Lilia M. Beauchamp Division of Organic Chemistry, Glaxo Wellcome Co ... [4] I. Mahadevan and M. Rasmussen, J. Heterocyclic Chem., 29 ...

Related Articles:

Scaffold-hopping strategy: synthesis and biological evaluation of 5, 6-fused bicyclic heteroaromatics to identify orally bioavailable anticancer agents

[Tung, Yen-Shih; Coumar, Mohane Selvaraj; Wu, Yu-Shan; Shiao, Hui-Yi; Chang, Jang-Yang; Liou, Jing-Ping; Shukla, Paritosh; Chang, Chun-Wei; Chang, Chi-Yen; Kuo, Ching-Chuan; Yeh, Teng-Kuang; Lin, Chin-Yu; Wu, Jian-Sung; Wu, Su-Ying; Liao, Chun-Chen; Hsieh, Hsing-Pang Journal of Medicinal Chemistry, 2011 , vol. 54, # 8 p. 3076 - 3080]

Discovery of [3-(4, 5, 7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo [2, 3-b] pyridin-1-yl] acetic acids as highly potent and selective inhibitors of aldose reductase for …

[Bioorganic and Medicinal Chemistry Letters, , vol. 19, # 7 p. 2006 - 2008]

Scaffold-hopping strategy: synthesis and biological evaluation of 5, 6-fused bicyclic heteroaromatics to identify orally bioavailable anticancer agents

[Journal of Medicinal Chemistry, , vol. 54, # 8 p. 3076 - 3080]

Scaffold-hopping strategy: synthesis and biological evaluation of 5, 6-fused bicyclic heteroaromatics to identify orally bioavailable anticancer agents

[Journal of Medicinal Chemistry, , vol. 54, # 8 p. 3076 - 3080]

Scaffold-hopping strategy: synthesis and biological evaluation of 5, 6-fused bicyclic heteroaromatics to identify orally bioavailable anticancer agents

[Journal of Medicinal Chemistry, , vol. 54, # 8 p. 3076 - 3080]

More Articles...